We are a world-leading consumer health company with a clear purpose to deliver better everyday health with humanity.
Learn more about why we are well positioned to play a vital role for people all around the world.
Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally.
Learn more about our brand categories and our strong portfolio of brands.
How we’re helping to break down the social and environmental barriers that hold people back from better everyday health.
Being a responsible business is one of Haleon's four strategic priorities. See how we performed in 2022.
All the latest news and information from Haleon.
Follow us on social media.
The future of everyday health is changing and we’re the people changing it. Nowhere else will you find an opportunity quite like this.
Where you choose to work matters, both to you, and to us.
Collapse navigation.
Who we are
At Haleon, we are committed to operating with strong corporate governance. We believe our governance structure underpins our ability to deliver the Group's strategy to create long-term value and benefit for our shareholders and stakeholders.
This section provides information on how Haleon is governed, including details on our Board and Committees, and compliance with UK and US corporate governance standards.
As a company with a premium listing on the London Stock Exchange, Haleon is subject to the provisions of the UK Corporate Governance Code (the “Code”), which can be found on the Financial Reporting Council’s website. For the year ended 31 December 2024, the Board considers that it complied in full with the provisions of the UK Corporate Governance Code 2018. Further details can be read in theAnnual Report and Form 20-F 2024.
Haleon is listed on the New York Stock Exchange (NYSE), and is a "foreign private issuer" under US securities laws and is subject to certain US securities laws and regulations, including the Sarbanes-Oxley Act of 2002 and the NYSE listing standards. As a foreign private issuer, the NYSE listing standards in general permit Haleon to follow UK corporate governance practices instead of those that apply to US companies, provided that any significant ways in which its practices differ are disclosed in the Annual Report and Form 20-F.
Information on our corporate governance practices and performance are outlined in theAnnual Report and Form 20-F 2024.
Articles of Association
The articles of association were approved by special resolution at a general meeting of Haleon plc on 31 May 2022.
Discover the responsibilities of the Board, our various Board Committees and the roles and responsibilities of the Chair, CEO and Senior Independent Director.
The Board of Directors takes collective responsibility for the overall management and performance of the Company.
Related